Scribd
Upload
120 views18 pages

Rh Isoimmunization Prevention in India

In India, Rh incompatibility affects 5-10% of cases, with sensitization primarily occurring during delivery. Rh0(D) immune globulin (RhIG) is used to prevent Rh isoimmunization in Rh-negative mothers and to treat Rh-positive individuals with ITP. The mechanism involves rapid clearance of Rh(D) positive red blood cells through interaction with immune cells, preventing sensitization during various pregnancy-related situations.

Uploaded by

Deepti Kukreti
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
120 views18 pages

Rh Isoimmunization Prevention in India

In India, Rh incompatibility affects 5-10% of cases, with sensitization primarily occurring during delivery. Rh0(D) immune globulin (RhIG) is used to prevent Rh isoimmunization in Rh-negative mothers and to treat Rh-positive individuals with ITP. The mechanism involves rapid clearance of Rh(D) positive red blood cells through interaction with immune cells, preventing sensitization during various pregnancy-related situations.

Uploaded by

Deepti Kukreti
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

INTRODUCTION

• In India the incidence of the Rh incompatibility is about 5-10% from


the hospital statistics. Less than 1ml of Rh- positive blood was shown
to sensitize volunteers with Rh- negative blood. In 90% of cases
sensitization occurs during delivery.
• Rh0(D) immune globulin (RhIG) is a medication used to prevent Rh
isoimmunization in mother who are Rh negative and to treat
idiopathic thrombocytopenia purpura(ITP) in Rh positive. It is often
given both during and following delivery.
MECHANISM OF ACTION

 Successful prophylaxis of RhD immunization by anti –D immunoglobulin is associated with a rapid


elimination of Rh(D) positive red blood cells (RBC) from the circulation of Rh(D) negative individuals.
 This clearance is mainly due to interaction of the anti-D coated RBCs with Fc gamma receptors bearing
mononuclear cells.

• The mode of action of anti-D may be merely


• To clear the D-positive cells from the circulation to the spleen by interaction of the IgG- coated red cells with
macrophages bearing IgG Fc receptors resulting in phagocytosis or lysis of the red cells.
• To prevent Rh isoimmunization in a non-sensitized Rh negative mother in following cases

1. First trimester:- spontaneous/ induced abortion, ectopic gestation.


2. Second trimester:- amniocentesis, second trimester MTP, fetoscopy.
3. Third trimester:- external cephalic version, antepaturm hemorrhage.
4. Delivery:- normal, forceps, vacuum extraction, LSCS. Postnatal women for non- sensitized women>-16
years who are Rh negative.

You might also like